| 113.0313 -0.444 (-0.39%) | 05-08 15:51 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 134.42 | 1-year : | 157 |
| Resists | First : | 115.08 | Second : | 134.42 |
| Pivot price | 113.05 |
|||
| Supports | First : | 111.95  |
Second : | 110.01 |
| MAs | MA(5) : | 113.34 |
MA(20) : | 113.2 |
| MA(100) : | 113.24 |
MA(250) : | 109.12 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 67.7 |
D(3) : | 61.5 |
| RSI | RSI(14): 52.3 |
|||
| 52-week | High : | 120.13 | Low : | 96.71 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ FXH ] has closed above bottom band by 49.1%. Bollinger Bands are 48.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 114.16 - 114.78 | 114.78 - 115.3 |
| Low: | 111.21 - 112 | 112 - 112.66 |
| Close: | 111.84 - 113.05 | 113.05 - 114.04 |
The First Trust Health Care AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index.
Sat, 09 May 2026
Stock List: Research Stocks from Around the World - GuruFocus
Sat, 02 May 2026
Avoiding Lag: Real-Time Signals in (FXH) Movement - Stock Traders Daily
Tue, 21 Apr 2026
Discipline and Rules-Based Execution in FXH Response - Stock Traders Daily
Mon, 20 Apr 2026
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? - Yahoo Finance
Mon, 13 Apr 2026
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Yahoo Finance
Mon, 26 Jan 2026
What's Going On With United Therapeutics Stock Monday? - United Therapeutics (NASDAQ:UTHR) - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|